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Chronic anal fissure (CAF) is a common painful clinical disease and its pathogenesis remains
poorly understood. After failure of pharmacological therapy, that is the first-line treatment, sur-
gical sphincterotomy remains the treatment of choice although it is followed by a high rate of anal
incontinence resulting from the sphincter damage; therefore, the research of a sphincter-saving
surgical option has become an important goal. The aim of this study was to evaluate the mano-
metric modifications and the incidence of anal incontinence after fissurectomy and anoplasty with
advancement skin flap in patients affected by CAF with hypertonia of the internal anal sphincter
(IAS). Fifteen patients affected by CAF with hypertonia of IAS, unresponsive to medical therapy,
were enrolled. All subjects underwent fissurectomy and anoplasty with advancement skin flap.
Anorectal manometry was performed preoperatively and after 6 and 12 months from surgery.
Maximum resting pressure (MRP), maximum squeeze pressure (MSP), ultraslow wave activity
(USWA), fissure healing, anal continence, and postoperative complications were recorded. All
patients healed within 30 days from surgery. No intra- or postoperative complications were
recorded except for a case of partial donor site break. No significant modifications of MSP were
detected. Six months after surgery, MRP was higher with respect to healthy subjects but signif-
icantly reduced in comparison to baseline levels. At 12 months, it was higher have versus 6-month
values but significantly lower versus preoperative values. USWAwas significantly represented in
patients with CAF versus healthy subject. Both at 6 and 12 months, they decreased significantly
with respect to preoperative values without significant differences versus healthy subjects. Both at
6 and 12 months, anal continence did not differ with respect to preoperative time. The fissurectomy
with anoplasty resulted in a high healing rate without surgical sequelae or anal incontinence. Also, it
was able to reduce IAS pressure in the samemanner as surgical sphincterotomy or forceful dilatation.
C HRONIC ANAL FISSURE (CAF) is a common painfulclinical disease. According to the literature, it
seems that CAF affects approximately 10 per cent of
patients with proctologic diseases. In England, from
2005 to 2006, the incidence of hospitalization for CAF
was 1.56 cases per 10,000 people.1 Data obtained from
the Italian Centers of Coloproctology during 2009
showed that they observed 5199 patients affected by
CAF of whom 1924 (approximately 37%) underwent
surgery.2 The pathogenesis of CAF is poorly un-
derstood, but it is believed to result from the combina-
tion of internal anal sphincter (IAS) hypertonia, relative
ischemia, and anal canal trauma. The role of hypertonia
of the IAS in the genesis of CAF remains not well de-
fined. Relief of the spasm has been associated with
relief of pain and healing of the fissure. It is now well
accepted that the first-line treatment of CAF is phar-
macological, although, after the failure of conservative
therapy, lateral internal sphincterotomy is considered
the treatment of choice for CAF. This procedure is able
to reduce permanently the maximum resting pressure
(MRP) of the anal canal allowing fissure healing in
more than 95 per cent of cases,3 but it may be followed
by soiling in a significant number of patients. The sig-
nificant traumatizing complication of incontinence led
the surgeons to research for surgical procedures that
preserve structural and functional integrity of the IAS
and, to date, the fissurectomy results in the procedure
being the most commonly used. This technique was
recently used alone4–6 and associated with a chemical
sphincterotomy7–13 or it was associated with anoplasty
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using an advancement cutaneous14–24 or mucosal flap25
with an incidence of healing comparable to lateral in-
ternal sphincterotomy. The aim of this study was to
evaluate some manometric modifications and the in-
cidence of anal incontinence after fissurectomy and
anoplasty with an advancement flap in patients af-
fected by CAF with hypertonia of IAS.
Materials and Methods
Fifteen male patients affected by posterior CAF with
hypertonia of IAS unresponsive to medical treatment
were enrolled in this prospective study from November
2009 to December 2010. All subjects gave written
informed consent, and the local ethics committee ap-
proved the study. Exclusion criteria were the presence of
multiple fissures, fistulas in ano, syphilis, inflammatory
bowel disease, anal abscess, malignant disease, and
previous anorectal surgery. CAF resistant to medical
treatment was defined as those that failed to heal after
topical medical therapy and a high-fiber dietary sup-
plementation. Preoperative anorectal manometry was
performed at least 4 weeks after the cessation of glyc-
eryl trinitrate ointment or calcium channel blocker
therapy and at 15 weeks after toxin botulinum injection.
A manometric control was repeated 6 and 12 months
after surgery. The manometry was carried out by a
manometric sensor (2.1 mm external diameter) with
four circle orifices and with a latex microballoon at its
extremity (Marquat C87; Boissy, St-Leger, France). The
machine was connected to a polygraph (Narco; Byo-
System MMS 200, Houston, TX) using the station pull-
through method with perfusion of normal saline and the
patient was lying in the right lateral position. CAF with
hypertonia was defined as those whose MRP values
were higher than 85 mmHg.26 On manometry, MRP and
maximum squeeze pressure (MSP) were defined as
maximum pressure detected, respectively, on resting
and after voluntary contraction. Ultraslow wave activity
(USWA) was defined as pressure waves with frequency
of less than 2/min and an amplitude greater than 25 cm
H2O. All patients underwent fissurectomy and anoplasty
with advancement skin flap lying in a gynecological
position under spinal anesthesia. After injection of 5 mL
local anesthetic solution (100 mg clonitrate mepivacaine
and 0.025 mg L-adrenaline), four Kocher pliers were
located in the proximity of mucous–cutaneous junction,
respectively, at 3, 6, 9, and 12 hours providing good
exposure of the anal canal; subsequently, the fibrotic
edges were excised with a scalpel until normal non-
fibrotic anodermal tissue showed sufficient bleeding.
The sentinel skin tags and hypertrophied anal papilla at
the level of the dentate line were excised, when they
were present, according to Gupta and Kalaskar.27 The
tissue at the base of the fissure was curetted until there
were clean muscle fibers of the IAS. There was no use
of diathermy and careful attention was given not to
damage the IAS. Standard advancement anoplasty was
performed using a flap of healthy skin tissue, which was
mobilized and advanced with its blood supply to fill the
defect. The flap was secured without tension to the anal
canal and the skin was closed tension-free in a V-Y
manner behind the advanced flap. Before surgery, all
patients received a small-volume phosphate–saline en-
ema. The metronidazole was administered intrave-
nously with a dosage of 500 mg 1 hour before surgery
and subsequently three times daily per os with a dosage
of 250 mg for 2 weeks. During the first 2 weeks after
surgery, patients took a variable doses of psyllium fi-
bers. A laxative preparation (sennosides) was given
orally to subjects who had not yet passed stools 3 days
after surgery. Enema, suppositories, and all rectal ma-
nipulations were avoided. Immediately after surgery, all
patients received 100 mg diclofenac intramuscularly
for analgesia and they were instructed to take 100 mg
nimesulide tablets as requested and a nifedipine plus
lidocaine cream three times daily until complete heal-
ing. The primary goals were the evaluation of complete
fissure healing, modifications of anal pressure, and anal
continence. The secondary goal included immediate
and long-time complications (i.e., anal stenosis, keyhole
deformity, urinary retention) that were recorded on pro
forma. Complete healing was defined as complete epi-
thelialization of the advancement skin flap. Anal in-
continence was assessed preoperatively and after 1, 6,
and 12 months from the surgical operation using the
Pescatori28 grading system: A, incontinence for flatus
and mucus; B, liquid stool; C, solid stool; and 1 for
occasional, 2 for weekly, and 3 for daily. The patients
were examined until they were completely healed and
they were also checked at 6 and 12 months after the
surgical operation. Independently of these scheduled
appointments, patients were seen on request. The con-
trol group consisted of a matched 18 healthy subjects
(36.6 ± 15.6 years) who had previously not reported
symptoms related to any anorectal diseases.
Statistical Analysis
The data were analyzed by standard statistical
methods and the results were expressed as means ±
standard deviation. Differences between continuous
data were compared using Student t test for paired and
unpaired samples, whereas differences between per-
centages were analyzed using Fisher test. Probability
values of < 0.05 were considered significant.
Results
Demographic and clinical characteristics of patients
are reported in Table 1.
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No intraoperative complications were observed. All
patients healed completely within 30 days from sur-
gery. No cases of urinary retention, anal stenosis, or
keyhole deformity were observed. No necrosis of the
transposed flap was detected. The only complications,
recorded postoperatively, were of slight entity and in
no case required further surgery; in particular, one in-
fection with a partial break of the donor site was
detected. At 12 months follow-up, in no case was further
surgery needed.
Maximum Resting Pressure and Anal Continence
In healthy control subjects, MRP and MSP values
were 68.1 ± 12.3 (mean ± standard deviation) and
112 ± 36.2 mmHg, respectively. Among patients with
CAF, preoperative values of MRP were significantly
higher as compared with healthy subjects (98.7 ±
18.5; P 4 0.0001), whereas MSP values were only
slightly increased (127.8 ± 31.8; P 4 0.1075). At 6
and 12 months after surgery, MSP values not signif-
icantly differed as compared both with preoperative
levels and healthy control subjects (data not shown).
At 6 months follow-up, MRP values decreased sig-
nificantly with respect to the preoperative values
(P 4 0.0012) but they remained higher, even not in
a significant way, as compared with healthy subjects
(P 4 0.0763). At 12 months follow-up, MRP values
were higher but not significantly as compared with
those observed after 6 months, but they were sig-
nificantly lower as compared with baseline values
(P 4 0.0195). As compared with healthy controls,
MRP values were significantly increased (P 4
0.0014) (Table 2).
During manometry, the presence of USWA was
detected only in two of 18 healthy subjects; in patients
with CAF, the USWA rate was 11 of 15 (73%). A
comparison among healthy subjects and patients with
CAF showed a significant difference (P 4 0.0004).
Six months after surgery, the patients with USWA
decreased significantly (P 4 0.0092) with respect to
preoperative assessment, whereas no differences were
detected in healthy subjects. At 12 months follow-up,
the subjects with USWA were lower in comparison to
preoperative subjects (P4 0.0268) but they were not
significantly higher as compared with healthy subjects
(P4 0.3747); a comparison between 6 and 12 months
showed a significant difference (P 4 1) (Fig. 1).
Preoperatively, one patient reported anal incon-
tinence classified as A2 according to the Pescatori
grading system. After surgery, anal incontinence
was present only in the patient with preoperative
incontinence. At 1, 6, and 12 months follow-up, the
level of incontinence in this patient was similar to
preoperatively.
Discussion
The results obtained show that fissurectomy and
anoplasty with advancement flap is a surgical procedure
that allows a high incidence of fissure healing and a low
incidence of complications with no alterations of anal
continence. At 6 months follow-up, MRP values were
lower than preoperative values and similar as compared
TABLE 1. Clinical and Demographic Characteristics of
Patients with Chronic Anal Fissure
No. Per cent
Gender (male) 15 —
Age (years) 29.3 ± 10.2 —
Hypertrophied anal papilla 13 87






Months (mean ± standard
deviation)
13.5 ± 8.2
TABLE 2. MRP Values Given as Mean ± Standard Deviation in
Healthy Subjects and in Patients with Chronic Anal Fissure
Before and after Fissurectomy and Anoplasty
MRP (mmHg)
Healthy 68.1 ± 12.3
Pre 98.7 ± 18.5
6 months 76.3 ± 18.3
12 months 85.1 ± 15.7
Student’s t test was used for statistical analysis. Statistical
results: pre vs healthy, P 4 0.0001; 6 months vs pre, P 4
0.0012; 6 months vs healthy, P 4 0.0763; 12 months vs
healthy, P4 0.0014; 12 months vs pre, P4 0.0195; 12 months
vs 6 months, P 4 0.0845.
MRP, maximum resting pressure.
FIG. 1. Ultraslow wave activity (USWA) gave as percentage in
healthy and in patients with chronic anal fissure (CAF) before and
after fissurectomy and anoplasty. Fisher test was used for statistical
analysis. Statistical results: pre vs healthy, P4 0.0004; 6 months
vs pre, P4 0.0092, 6 months vs healthy, P4 0.6390, 12 months vs
healthy, P4 0.3747, 12 months vs pre, P4 0.0268, 12 months vs
6 months, P 4 1.
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with healthy subjects; at 12 months, they were slightly
higher with respect to those detected after 6 months
follow-up, remaining more as compared with preopera-
tive values although they were higher than healthy sub-
jects. These results are similar to the results obtained
after lateral internal sphincterotomy29 and after pneu-
matic balloon dilatation.30
The aid of CAF treatment is in healing the patient
without immediate or long-time complications. Anal
incontinence, even if regarding only gas, is the most
serious complication that can compromise quality of
life and it can be more disabling than CAF. The anal
incontinence can occur immediately or at a long distance
after surgery and it can be temporary or permanent. The
incidence of incontinence postsphincterotomy or stretch
of the IAS varies from zero in some studies reaching up
to 31 per cent in other cases.31 This extreme variability
can depend on the extent of sphincterotomy, the defini-
tion of anal incontinence, and the differences in follow-
up.32 Pernikoff et al.33 found that fecal incontinence after
internal sphincterotomy became more common with
time. Casillas et al.31 reported 298 patients who under-
went a sphincterotomy for CAF with a mean follow-up
of 4.3 years reporting temporary incontinence in 31 per
cent and persistent gas incontinence in 30 per cent. In
a recent study, Levin et al.34 showed that the incidence of
the first anal incontinence event in approximately 5.5 per
cent of patients at least 4 years after surgery.
IAS has an essential role to preserve anal continence.
The injury of the IAS can be functionally compensated
immediately after surgery. However, in some patients,
progression from functionally compensated to func-
tionally uncompensated anal sphincter damage may
occur.34 Delayed incontinence may be associated with
other cofactors accumulating over time, or more likely,
anal fissure surgery may accelerate the physiological
age-related weakening of the anal sphincter mechanism.
The role of hypertonia of the IAS in pathogenesis of
the CAF remains unclear. Several studies showed that
a reduction of MRP levels with medical therapy is
associated with a high incidence of fissure healing.
However, Pitt et al.,35 in a double-blind randomized
placebo-controlled trial, observed that oral indoramin
(a-adrenoreceptor antagonist) reduced MRP but had
no satisfactory effect on fissure healing. Other stud-
ies36–38 confirmed no significantly differences between
healing and not healing CAF when manometric findings
were compared. Recently, some surgical procedures
such as fissurectomy alone or fissurectomy associated
with advancement flap showed a similar incidence of
fissure healing compared with the sphincterotomy or the
anal dilatation. According to these observations, a re-
duction of anal pressure as a consequence obtained
with pharmacological or surgical therapy does not
represent a prerequisite for CAF healing.39
During the fissurectomy with or without advance-
ment flap, some steps may compromise the integrity of
the IAS. Therefore, it is necessary to perform a fissur-
ectomy with a scalpel to avoid excision or cauteriza-
tion of the IAS fibers. Also, anal retractors (Parks,
Eisenhammer, Fergusson) have not been used; when it
became necessary, they have been used slightly and for
a short period of time. Zimmermann et al.,40 in a pro-
spective randomized clinical trial showed, that patients,
treated with a transanal advancement flap for repair of a
high transsphincteric fistula, have a significant reduction
of MRP and an increase of anal incontinence after use
of a Parks retractor as compared with use of a Scott re-
tractor.40 Van Tets et al.41 who have conducted a study
in patients who underwent closed hemorrhoidectomy
showed that the reduction of MRP was, respectively,
23 and 8 per cent in ratio of the use or not the use of
a Parks retractor, respectively. Van Test et al.41 suggested
that overstretching of the anal sphincters by a Parks re-
tractor results in rupture of small nerve branches and
consequently to denervation of muscle fibers. In animal
studies, it has been shown that prolonged stretching can
lead to local necrosis of external anal sphincter fibers.42
In this study, a good exposure of anal canal was obtained
using four Kocher pliers at 3, 6, 9, and 12 hours, re-
spectively, to avoid the use of an anal retractor.
In conclusion, the fissurectomy with anoplasty resul-
ted in an high fissure healing rate reporting no case of
fecal incontinence at 2 years follow-up. In addition, this
procedure resulted in being able to reduce IAS pressure
in the same manner of the partial or total sphincterotomy
or forceful anal dilatation.
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